Pictet Asset Management Holding Sa Protagonist Therapeutics, Inc Transaction History
Pictet Asset Management Holding Sa
- $98.2 Billion
- Q3 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 822,212 shares of PTGX stock, worth $69.6 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
822,212
Previous 751,977
9.34%
Holding current value
$69.6 Million
Previous $41.6 Million
31.42%
% of portfolio
0.06%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding PTGX
# of Institutions
296Shares Held
66.9MCall Options Held
139KPut Options Held
40.7K-
Farallon Capital Management LLC San Francisco, CA6.2MShares$524 Million1.78% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$487 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.76MShares$487 Million5.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.26MShares$360 Million0.0% of portfolio
-
State Street Corp Boston, MA3.17MShares$268 Million0.01% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $4.15B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...